Araujo GLV, Murta Amaral L, Ponzio V, Rocha JL, et al. Economic and budgetary impact evaluation of isavuconazole (Cresemba(R)) versus voriconazole (Vfend(R)) for the treatment of patients with possible invasive aspergillosis from the perspective of the Brazilian supplementary health system. PLoS One 2024;19:e0299056.
PMID: 38427635